纳斯达克生物科技指数
Search documents
纳斯达克生物科技指数上涨2.2%
Mei Ri Jing Ji Xin Wen· 2025-10-01 14:22
Group 1 - The Nasdaq Biotechnology Index rose by 2.2%, reaching its highest level since 2021 [1]
标普500指数初步收涨0.1%，电信、金融、房地产板块至多涨约0.6%，科技板块则跌超0.2%，原材料板块跌超0.4%，能源板块跌1.2%。纳斯达克100指数初步收涨0.3%，成分股AppLovin涨6.2%，Autodesk涨5%，Palantir涨4.9%，MSTR涨3.8%，PayPal涨3.5%，格芯、高通、拉姆研究、拼多多ADR则至少收跌2%，露露柠檬跌3.2%，美光科技跌4.8%。费城半导体指数跌0.8%，银行指数涨0.5%；科技股七巨头指数跌0.1%，“特朗普关税输家指数”跌0.8%；纳斯达克
news flash· 2025-07-14 20:02
Core Insights - The S&P 500 index saw a preliminary increase of 0.1%, with telecommunications, financials, and real estate sectors rising by up to 0.6%, while the technology sector declined by over 0.2% [1] - The Nasdaq 100 index experienced a preliminary rise of 0.3%, with notable gains from AppLovin (up 6.2%), Autodesk (up 5%), and Palantir (up 4.9%), while companies like Micron Technology fell by 4.8% [1] - The Philadelphia Semiconductor Index dropped by 0.8%, contrasting with a 0.5% increase in the banking index [1] Sector Performance - Telecommunications, financials, and real estate sectors showed resilience with gains of up to 0.6% [1] - The technology sector faced challenges, with a decline of over 0.2% and significant losses in major tech stocks [1] - The Nasdaq Biotechnology Index rose by 1%, indicating positive movement in the biotech sector [1]
纳斯达克生物科技指数收涨1.55%。成分股Akero Therapeutics收涨22.71%，Sana Biotechnology涨22.02%，89bio涨20.97%表现第三，新冠疫苗概念股CureVac NV ADR涨10.47%、莫德纳涨6.31%表现靠前。Anavex Life Sciences则收跌9.95%表现倒数第三，Prime Medicine跌15.01%，Alumis跌16.89%。
news flash· 2025-05-20 20:50
Market Performance - The NASDAQ Biotechnology Index increased by 1.55%, closing at 4,177.9 points [1][2] - Notable gainers included Akero Therapeutics, which rose by 22.71%, and Sana Biotechnology, which increased by 22.02% [1][2] - Other significant performers were 89bio with a 20.97% rise, CureVac NV ADR up by 10.47%, and Moderna gaining 6.31% [1][2] Decliners - Anavex Life Sciences experienced a decline of 9.95%, while Prime Medicine fell by 15.01% [1][2] - Alumis saw a significant drop of 16.89% [1][2] Trading Volume - Akero Therapeutics had a trading volume of 6.77 million shares, while Sana Biotechnology traded 10.2 million shares [2] - 89bio recorded a trading volume of 7.16 million shares [2]
纳斯达克生物科技指数跌幅扩大至5.38%。成分股Syndax Pharmaceuticals跌21.37%，Taysha Gene跌18.25%，uniQure NV跌17.94%表现目前倒数第三。
news flash· 2025-05-06 17:14
Group 1 - Syndax Pharmaceuticals experienced a significant decline of 21.37% [1] - Taysha Gene saw a drop of 18.25% [1] - uniQure NV reported a decrease of 17.94%, ranking among the lowest performers [1] Group 2 - The latest price for Syndax Pharmaceuticals is 10.63, with a trading volume of 3.85 million [2] - Taysha Gene's latest price is 2.015, with a trading volume of 3.54 million [2] - uniQure NV's latest price is 13.080, with a trading volume of 1.73 million [2]
5月7日电，纳斯达克生物科技指数跌幅扩大至5.3%。
news flash· 2025-05-06 17:10
Group 1 - The Nasdaq Biotechnology Index has experienced a decline, with a drop of 5.3% [1]